By categorizing tumor-specific CNA regions in metastases, we found that alterations of oncogenes and tumor suppressors, for instance, tumor suppressor PMS2 and oncogenes TFPT, ZNF331, and others, may be linked to metastatic progression (Additional file 2: Figure S7 and Additional file 1: Table S7). This evidence concerns the gene TFPT and neoplasm.